BCL2 and breast cancer: It has been reported that Bcl-2 antagonized the autophagy pathway, subverted the internal protein quality and genome stability and promoted the growth of breast cancer cells, indicating that Beclin 1 and Bcl-2 can be served as attractive targets for cancer therapy [93].